News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
807,986 Results
Type
Article (65731)
Company Profile (399)
Press Release (741838)
Multimedia
Podcasts (143)
Webinars (24)
Section
Business (221761)
Career Advice (3022)
Deals (38044)
Drug Delivery (148)
Drug Development (87863)
Employer Resources (199)
FDA (17799)
Job Trends (16581)
News (376922)
Policy (36966)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2995)
Academic (2)
Accelerated approval (39)
Adcomms (35)
Allergies (165)
Alliances (54334)
ALS (192)
Alzheimer's disease (1816)
Antibody-drug conjugate (ADC) (364)
Approvals (18010)
Artificial intelligence (631)
Autoimmune disease (194)
Automation (48)
Bankruptcy (394)
Best Places to Work (12444)
BIOSECURE Act (21)
Biosimilars (208)
Biotechnology (245)
Bladder cancer (174)
Brain cancer (68)
Breast cancer (688)
Cancer (5294)
Cardiovascular disease (468)
Career advice (2577)
Career pathing (44)
CAR-T (315)
CDC (64)
Celiac Disease (2)
Cell therapy (838)
Cervical cancer (41)
Clinical research (74644)
Collaboration (1944)
Company closure (4)
Compensation (1235)
Complete response letters (77)
COVID-19 (2975)
CRISPR (108)
C-suite (974)
Cystic fibrosis (152)
Data (6711)
Decentralized trials (2)
Denatured (49)
Depression (164)
Diabetes (544)
Diagnostics (7249)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (294)
Drug pricing (222)
Drug shortages (33)
Duchenne muscular dystrophy (259)
Earnings (94851)
Editorial (69)
Employer branding (25)
Employer resources (170)
Events (129360)
Executive appointments (1072)
FDA (21146)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1636)
Gene editing (229)
Generative AI (56)
Gene therapy (696)
GLP-1 (1136)
Government (5296)
Grass and pollen (8)
Guidances (388)
Healthcare (20675)
HIV (75)
Huntington's disease (55)
IgA nephropathy (89)
Immunology and inflammation (301)
Immuno-oncology (76)
Indications (135)
Infectious disease (3289)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (131)
Intellectual property (267)
Interviews (580)
IPO (17423)
IRA (60)
Job creations (4492)
Job search strategy (2102)
JPM (69)
Kidney cancer (20)
Labor market (97)
Layoffs (636)
Leadership (44)
Legal (9149)
Liver cancer (102)
Longevity (21)
Lung cancer (713)
Lymphoma (396)
Machine learning (48)
Management (65)
Manufacturing (894)
MASH (185)
Medical device (14985)
Medtech (15053)
Mergers & acquisitions (21738)
Metabolic disorders (1451)
mRNA (194)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (381)
Neuropsychiatric disorders (107)
Neuroscience (3232)
Neurotech (1)
NextGen: Class of 2026 (7400)
Non-profit (5064)
Now hiring (70)
Obesity (703)
Opinion (335)
Ovarian cancer (176)
Pain (231)
Pancreatic cancer (253)
Parkinson's disease (320)
Partnered (35)
Patents (545)
Patient recruitment (557)
Peanut (65)
People (65213)
Pharmaceutical (86)
Pharmacy benefit managers (32)
Phase 1 (23186)
Phase 2 (32643)
Phase 3 (24452)
Pipeline (6198)
Policy (346)
Postmarket research (3083)
Preclinical (10116)
Press Release (72)
Prostate cancer (271)
Psychedelics (60)
Radiopharmaceuticals (313)
Rare diseases (1008)
Real estate (6824)
Recruiting (79)
Regulatory (27488)
Reports (66)
Research institute (2705)
Resumes & cover letters (470)
Rett syndrome (31)
RNA editing (18)
RSV (88)
Schizophrenia (166)
Series A (277)
Series B (206)
Service/supplier (14)
Sickle cell disease (110)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (45)
Startups (4089)
State (2)
Stomach cancer (21)
Supply chain (118)
Tariffs (95)
The Weekly (92)
Vaccines (1165)
Venture capital (101)
Weight loss (472)
Women's health (104)
Worklife (23)
Date
Last 7 days (760)
Last 30 days (2994)
Last 365 days (31660)
2026 (5920)
2025 (32023)
2024 (37212)
2023 (42195)
2022 (53499)
2021 (58252)
2020 (57182)
2019 (50632)
2018 (38480)
2017 (35488)
2016 (35842)
2015 (41882)
2014 (35949)
2013 (31638)
2012 (33756)
2011 (34267)
2010 (33363)
Location
Africa (1028)
Alabama (90)
Alaska (7)
Arizona (342)
Arkansas (15)
Asia (46318)
Australia (8321)
California (12104)
Canada (3455)
China (1225)
Colorado (513)
Connecticut (532)
Delaware (357)
Europe (103870)
Florida (1798)
Georgia (396)
Hawaii (4)
Idaho (67)
Illinois (992)
India (79)
Indiana (559)
Iowa (23)
Japan (468)
Kansas (133)
Kentucky (46)
Louisiana (36)
Maine (73)
Maryland (1503)
Massachusetts (8819)
Michigan (371)
Minnesota (690)
Mississippi (7)
Missouri (144)
Montana (35)
Nebraska (29)
Nevada (135)
New Hampshire (88)
New Jersey (3252)
New Mexico (32)
New York (3199)
North Carolina (1634)
North Dakota (10)
Northern California (5912)
Ohio (361)
Oklahoma (21)
Oregon (45)
Pennsylvania (2431)
Puerto Rico (25)
Rhode Island (51)
South America (1414)
South Carolina (71)
South Dakota (1)
Southern California (4722)
Tennessee (194)
Texas (1901)
United States (43406)
Utah (366)
Vermont (1)
Virginia (288)
Washington D.C. (87)
Washington State (991)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
807,986 Results for "emmaus life sciences formerly known as emmaus medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emmaus Life Sciences Announces Strategic Transaction
December 30, 2025
·
5 min read
Press Releases
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
March 3, 2026
·
1 min read
Policy
Emmaus Life Sciences Reports Delayed Filing of Annual Report
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported that the filing of its Annual Report on Form 10-K for the year ended December 31, 2023 will be delayed.
April 15, 2024
·
3 min read
Policy
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that it has received marketing authorization from the Puerto Rico Department of Health for Endari®.
February 2, 2024
·
4 min read
Business
Emmaus Life Sciences Reports Management Changes
Emmaus Life Sciences, Inc. today reported that on August 18, 2023 the Board of Directors, including Yutaka Niihara, M.D., Ph.D, determined that Dr. Niihara would no longer serve as Chief Executive Officer of Emmaus, or as Chairman of the Board, in order to allow Dr. Niihara to pursue business opportunities in Ube, Japan and in India previously initiated by Emmaus.
August 23, 2023
·
5 min read
Press Releases
Verist Inc. Announces Relationship with Basil Systems to Strengthen Life Sciences Offering
February 26, 2026
·
3 min read
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Biotech Beach
Emmaus Life Sciences Reports Q3 2023 Financial Results
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported on its financial condition and results of operations as of and for the three and nine months ended September 30, 2023.
November 14, 2023
·
8 min read
Press Releases
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
February 18, 2026
·
1 min read
Business
Basel Life Sciences Scene Embraces International Companies, Startups
The Basel area is home to over 800 life sciences companies, including Novartis and Roche, according to nonprofit Basel Area Business & Innovation. The nonprofit’s CEO and a BeOne Medicines executive discuss the location’s evolution, advantages and future.
November 6, 2025
·
6 min read
·
Angela Gabriel
1 of 80,799
Next
